Loading…

Predicting lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma: collaboration between artificial intelligence and pathologists

Researchers have attempted to identify the factors involved in lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma (SCC). However, studies combining histopathological and clinicopathological information in prediction models are limited. We aimed to develop a highly accurate lymph node re...

Full description

Saved in:
Bibliographic Details
Published in:The journal of pathology. Clinical research 2024-09, Vol.10 (5), p.e12392-n/a
Main Authors: Adachi, Masahiro, Taki, Tetsuro, Kojima, Motohiro, Sakamoto, Naoya, Matsuura, Kazuto, Hayashi, Ryuichi, Tabuchi, Keiji, Ishikawa, Shumpei, Ishii, Genichiro, Sakashita, Shingo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4192-5b22889e0aafc842370bd7823c2de5cc53b4edba23055e587d04f6c0a4b67c053
container_end_page n/a
container_issue 5
container_start_page e12392
container_title The journal of pathology. Clinical research
container_volume 10
creator Adachi, Masahiro
Taki, Tetsuro
Kojima, Motohiro
Sakamoto, Naoya
Matsuura, Kazuto
Hayashi, Ryuichi
Tabuchi, Keiji
Ishikawa, Shumpei
Ishii, Genichiro
Sakashita, Shingo
description Researchers have attempted to identify the factors involved in lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma (SCC). However, studies combining histopathological and clinicopathological information in prediction models are limited. We aimed to develop a highly accurate lymph node recurrence prediction model for clinical stage T1‐2, N0 (cT1‐2N0) tongue SCC by integrating histopathological artificial intelligence (AI) with clinicopathological information. A dataset from 148 patients with cT1‐2N0 tongue SCC was divided into training and test sets. The prediction models were constructed using AI‐extracted information from whole slide images (WSIs), human‐assessed clinicopathological information, and both combined. Weakly supervised learning and machine learning algorithms were used for WSIs and clinicopathological information, respectively. The combination model utilised both algorithms. Highly predictive patches from the model were analysed for histopathological features. In the test set, the areas under the receiver operating characteristic (ROC) curve for the model using WSI, clinicopathological information, and both combined were 0.826, 0.835, and 0.991, respectively. The highest area under the ROC curve was achieved with the model combining WSI and clinicopathological factors. Histopathological feature analysis showed that highly predicted patches extracted from recurrence cases exhibited significantly more tumour cells, inflammatory cells, and muscle content compared with non‐recurrence cases. Moreover, patches with mixed inflammatory cells, tumour cells, and muscle were significantly more prevalent in recurrence versus non‐recurrence cases. The model integrating AI‐extracted histopathological and human‐assessed clinicopathological information demonstrated high accuracy in predicting lymph node recurrence in patients with cT1‐2N0 tongue SCC.
doi_str_mv 10.1002/2056-4538.12392
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1685a82c74b8467eabd5e58b18e3f05e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_1685a82c74b8467eabd5e58b18e3f05e</doaj_id><sourcerecordid>3094820093</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4192-5b22889e0aafc842370bd7823c2de5cc53b4edba23055e587d04f6c0a4b67c053</originalsourceid><addsrcrecordid>eNqFks1u1DAUhSMEolXpmh2yxIbNtP6JE4cNQiN-iirooqwt27nJeOTYUztpNTsegAXPyJPgzJRRy4aVretzP917fIriJcFnBGN6TjGvFiVn4oxQ1tAnxfGh8vTB_ag4TWmNMSac4JqWz4sj1hDeYM6Oi59XEVprRut75LbDZoV8aAFFMFOM4A0g65G5Jr9__KJfMRqD7ydA6WZSQ5gSMuAcMioa68Og3iITnFM6RDXa4JGG8Q7AIxVH21ljlcu0MbfYfodWvkUbNa6CC71NY3pRPOuUS3B6f54U3z9-uF5-Xlx--3SxfH-5MCVp6IJrSoVoACvVGVFSVmPd1oIyQ1vgxnCmS2i1ogxzDlzULS67ymBV6qo2ee2T4mLPbYNay020g4pbGZSVu0KIvZxHNg4kqQRXgpq61KKsalC6nZGaCGAd5pBZ7_aszaQHaA34MSr3CPr4xduV7MOtJISx_G1VJry5J8RwM0Ea5WDTbKzykD2WDDeloBg3LEtf_yNdhyn67JVkBDec8LqmWXW-V5kYUorQHaYhWM7JkXM25JwNuUtO7nj1cImD_m9OsqDaC-6sg-3_eHL55YruyX8AeYPQpg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3109515772</pqid></control><display><type>article</type><title>Predicting lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma: collaboration between artificial intelligence and pathologists</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Wiley Open Access</source><creator>Adachi, Masahiro ; Taki, Tetsuro ; Kojima, Motohiro ; Sakamoto, Naoya ; Matsuura, Kazuto ; Hayashi, Ryuichi ; Tabuchi, Keiji ; Ishikawa, Shumpei ; Ishii, Genichiro ; Sakashita, Shingo</creator><creatorcontrib>Adachi, Masahiro ; Taki, Tetsuro ; Kojima, Motohiro ; Sakamoto, Naoya ; Matsuura, Kazuto ; Hayashi, Ryuichi ; Tabuchi, Keiji ; Ishikawa, Shumpei ; Ishii, Genichiro ; Sakashita, Shingo</creatorcontrib><description>Researchers have attempted to identify the factors involved in lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma (SCC). However, studies combining histopathological and clinicopathological information in prediction models are limited. We aimed to develop a highly accurate lymph node recurrence prediction model for clinical stage T1‐2, N0 (cT1‐2N0) tongue SCC by integrating histopathological artificial intelligence (AI) with clinicopathological information. A dataset from 148 patients with cT1‐2N0 tongue SCC was divided into training and test sets. The prediction models were constructed using AI‐extracted information from whole slide images (WSIs), human‐assessed clinicopathological information, and both combined. Weakly supervised learning and machine learning algorithms were used for WSIs and clinicopathological information, respectively. The combination model utilised both algorithms. Highly predictive patches from the model were analysed for histopathological features. In the test set, the areas under the receiver operating characteristic (ROC) curve for the model using WSI, clinicopathological information, and both combined were 0.826, 0.835, and 0.991, respectively. The highest area under the ROC curve was achieved with the model combining WSI and clinicopathological factors. Histopathological feature analysis showed that highly predicted patches extracted from recurrence cases exhibited significantly more tumour cells, inflammatory cells, and muscle content compared with non‐recurrence cases. Moreover, patches with mixed inflammatory cells, tumour cells, and muscle were significantly more prevalent in recurrence versus non‐recurrence cases. The model integrating AI‐extracted histopathological and human‐assessed clinicopathological information demonstrated high accuracy in predicting lymph node recurrence in patients with cT1‐2N0 tongue SCC.</description><identifier>ISSN: 2056-4538</identifier><identifier>EISSN: 2056-4538</identifier><identifier>DOI: 10.1002/2056-4538.12392</identifier><identifier>PMID: 39159053</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Artificial Intelligence ; Cancer ; Carcinoma, Squamous Cell - pathology ; Cell culture ; Datasets ; Dissection ; Female ; Gene expression ; Humans ; Inflammation ; Lymph nodes ; Lymph Nodes - pathology ; lymphatic metastasis ; Lymphatic Metastasis - pathology ; Lymphatic system ; Machine learning ; Male ; Medical prognosis ; Metastasis ; Middle Aged ; Neoplasm Recurrence, Local - pathology ; Neoplasm Staging ; Neural networks ; Original ; Pathologists ; pathology ; Prediction models ; Predictive Value of Tests ; Squamous cell carcinoma ; Squamous Cell Carcinoma of Head and Neck - pathology ; Support vector machines ; Tomography ; Tongue ; tongue neoplasms ; Tongue Neoplasms - pathology ; Tumors</subject><ispartof>The journal of pathology. Clinical research, 2024-09, Vol.10 (5), p.e12392-n/a</ispartof><rights>2024 The Author(s). published by The Pathological Society of Great Britain and Ireland and John Wiley &amp; Sons Ltd.</rights><rights>2024 The Author(s). The Journal of Pathology: Clinical Research published by The Pathological Society of Great Britain and Ireland and John Wiley &amp; Sons Ltd.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4192-5b22889e0aafc842370bd7823c2de5cc53b4edba23055e587d04f6c0a4b67c053</cites><orcidid>0000-0001-6489-446X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3109515772/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3109515772?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,11543,25734,27905,27906,36993,36994,44571,46033,46457,53772,53774,74875</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39159053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adachi, Masahiro</creatorcontrib><creatorcontrib>Taki, Tetsuro</creatorcontrib><creatorcontrib>Kojima, Motohiro</creatorcontrib><creatorcontrib>Sakamoto, Naoya</creatorcontrib><creatorcontrib>Matsuura, Kazuto</creatorcontrib><creatorcontrib>Hayashi, Ryuichi</creatorcontrib><creatorcontrib>Tabuchi, Keiji</creatorcontrib><creatorcontrib>Ishikawa, Shumpei</creatorcontrib><creatorcontrib>Ishii, Genichiro</creatorcontrib><creatorcontrib>Sakashita, Shingo</creatorcontrib><title>Predicting lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma: collaboration between artificial intelligence and pathologists</title><title>The journal of pathology. Clinical research</title><addtitle>J Pathol Clin Res</addtitle><description>Researchers have attempted to identify the factors involved in lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma (SCC). However, studies combining histopathological and clinicopathological information in prediction models are limited. We aimed to develop a highly accurate lymph node recurrence prediction model for clinical stage T1‐2, N0 (cT1‐2N0) tongue SCC by integrating histopathological artificial intelligence (AI) with clinicopathological information. A dataset from 148 patients with cT1‐2N0 tongue SCC was divided into training and test sets. The prediction models were constructed using AI‐extracted information from whole slide images (WSIs), human‐assessed clinicopathological information, and both combined. Weakly supervised learning and machine learning algorithms were used for WSIs and clinicopathological information, respectively. The combination model utilised both algorithms. Highly predictive patches from the model were analysed for histopathological features. In the test set, the areas under the receiver operating characteristic (ROC) curve for the model using WSI, clinicopathological information, and both combined were 0.826, 0.835, and 0.991, respectively. The highest area under the ROC curve was achieved with the model combining WSI and clinicopathological factors. Histopathological feature analysis showed that highly predicted patches extracted from recurrence cases exhibited significantly more tumour cells, inflammatory cells, and muscle content compared with non‐recurrence cases. Moreover, patches with mixed inflammatory cells, tumour cells, and muscle were significantly more prevalent in recurrence versus non‐recurrence cases. The model integrating AI‐extracted histopathological and human‐assessed clinicopathological information demonstrated high accuracy in predicting lymph node recurrence in patients with cT1‐2N0 tongue SCC.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Artificial Intelligence</subject><subject>Cancer</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Cell culture</subject><subject>Datasets</subject><subject>Dissection</subject><subject>Female</subject><subject>Gene expression</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Lymph nodes</subject><subject>Lymph Nodes - pathology</subject><subject>lymphatic metastasis</subject><subject>Lymphatic Metastasis - pathology</subject><subject>Lymphatic system</subject><subject>Machine learning</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Staging</subject><subject>Neural networks</subject><subject>Original</subject><subject>Pathologists</subject><subject>pathology</subject><subject>Prediction models</subject><subject>Predictive Value of Tests</subject><subject>Squamous cell carcinoma</subject><subject>Squamous Cell Carcinoma of Head and Neck - pathology</subject><subject>Support vector machines</subject><subject>Tomography</subject><subject>Tongue</subject><subject>tongue neoplasms</subject><subject>Tongue Neoplasms - pathology</subject><subject>Tumors</subject><issn>2056-4538</issn><issn>2056-4538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqFks1u1DAUhSMEolXpmh2yxIbNtP6JE4cNQiN-iirooqwt27nJeOTYUztpNTsegAXPyJPgzJRRy4aVretzP917fIriJcFnBGN6TjGvFiVn4oxQ1tAnxfGh8vTB_ag4TWmNMSac4JqWz4sj1hDeYM6Oi59XEVprRut75LbDZoV8aAFFMFOM4A0g65G5Jr9__KJfMRqD7ydA6WZSQ5gSMuAcMioa68Og3iITnFM6RDXa4JGG8Q7AIxVH21ljlcu0MbfYfodWvkUbNa6CC71NY3pRPOuUS3B6f54U3z9-uF5-Xlx--3SxfH-5MCVp6IJrSoVoACvVGVFSVmPd1oIyQ1vgxnCmS2i1ogxzDlzULS67ymBV6qo2ee2T4mLPbYNay020g4pbGZSVu0KIvZxHNg4kqQRXgpq61KKsalC6nZGaCGAd5pBZ7_aszaQHaA34MSr3CPr4xduV7MOtJISx_G1VJry5J8RwM0Ea5WDTbKzykD2WDDeloBg3LEtf_yNdhyn67JVkBDec8LqmWXW-V5kYUorQHaYhWM7JkXM25JwNuUtO7nj1cImD_m9OsqDaC-6sg-3_eHL55YruyX8AeYPQpg</recordid><startdate>202409</startdate><enddate>202409</enddate><creator>Adachi, Masahiro</creator><creator>Taki, Tetsuro</creator><creator>Kojima, Motohiro</creator><creator>Sakamoto, Naoya</creator><creator>Matsuura, Kazuto</creator><creator>Hayashi, Ryuichi</creator><creator>Tabuchi, Keiji</creator><creator>Ishikawa, Shumpei</creator><creator>Ishii, Genichiro</creator><creator>Sakashita, Shingo</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6489-446X</orcidid></search><sort><creationdate>202409</creationdate><title>Predicting lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma: collaboration between artificial intelligence and pathologists</title><author>Adachi, Masahiro ; Taki, Tetsuro ; Kojima, Motohiro ; Sakamoto, Naoya ; Matsuura, Kazuto ; Hayashi, Ryuichi ; Tabuchi, Keiji ; Ishikawa, Shumpei ; Ishii, Genichiro ; Sakashita, Shingo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4192-5b22889e0aafc842370bd7823c2de5cc53b4edba23055e587d04f6c0a4b67c053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Artificial Intelligence</topic><topic>Cancer</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Cell culture</topic><topic>Datasets</topic><topic>Dissection</topic><topic>Female</topic><topic>Gene expression</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Lymph nodes</topic><topic>Lymph Nodes - pathology</topic><topic>lymphatic metastasis</topic><topic>Lymphatic Metastasis - pathology</topic><topic>Lymphatic system</topic><topic>Machine learning</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Staging</topic><topic>Neural networks</topic><topic>Original</topic><topic>Pathologists</topic><topic>pathology</topic><topic>Prediction models</topic><topic>Predictive Value of Tests</topic><topic>Squamous cell carcinoma</topic><topic>Squamous Cell Carcinoma of Head and Neck - pathology</topic><topic>Support vector machines</topic><topic>Tomography</topic><topic>Tongue</topic><topic>tongue neoplasms</topic><topic>Tongue Neoplasms - pathology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adachi, Masahiro</creatorcontrib><creatorcontrib>Taki, Tetsuro</creatorcontrib><creatorcontrib>Kojima, Motohiro</creatorcontrib><creatorcontrib>Sakamoto, Naoya</creatorcontrib><creatorcontrib>Matsuura, Kazuto</creatorcontrib><creatorcontrib>Hayashi, Ryuichi</creatorcontrib><creatorcontrib>Tabuchi, Keiji</creatorcontrib><creatorcontrib>Ishikawa, Shumpei</creatorcontrib><creatorcontrib>Ishii, Genichiro</creatorcontrib><creatorcontrib>Sakashita, Shingo</creatorcontrib><collection>Wiley Open Access</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Biological Science Journals</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>The journal of pathology. Clinical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adachi, Masahiro</au><au>Taki, Tetsuro</au><au>Kojima, Motohiro</au><au>Sakamoto, Naoya</au><au>Matsuura, Kazuto</au><au>Hayashi, Ryuichi</au><au>Tabuchi, Keiji</au><au>Ishikawa, Shumpei</au><au>Ishii, Genichiro</au><au>Sakashita, Shingo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predicting lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma: collaboration between artificial intelligence and pathologists</atitle><jtitle>The journal of pathology. Clinical research</jtitle><addtitle>J Pathol Clin Res</addtitle><date>2024-09</date><risdate>2024</risdate><volume>10</volume><issue>5</issue><spage>e12392</spage><epage>n/a</epage><pages>e12392-n/a</pages><issn>2056-4538</issn><eissn>2056-4538</eissn><abstract>Researchers have attempted to identify the factors involved in lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma (SCC). However, studies combining histopathological and clinicopathological information in prediction models are limited. We aimed to develop a highly accurate lymph node recurrence prediction model for clinical stage T1‐2, N0 (cT1‐2N0) tongue SCC by integrating histopathological artificial intelligence (AI) with clinicopathological information. A dataset from 148 patients with cT1‐2N0 tongue SCC was divided into training and test sets. The prediction models were constructed using AI‐extracted information from whole slide images (WSIs), human‐assessed clinicopathological information, and both combined. Weakly supervised learning and machine learning algorithms were used for WSIs and clinicopathological information, respectively. The combination model utilised both algorithms. Highly predictive patches from the model were analysed for histopathological features. In the test set, the areas under the receiver operating characteristic (ROC) curve for the model using WSI, clinicopathological information, and both combined were 0.826, 0.835, and 0.991, respectively. The highest area under the ROC curve was achieved with the model combining WSI and clinicopathological factors. Histopathological feature analysis showed that highly predicted patches extracted from recurrence cases exhibited significantly more tumour cells, inflammatory cells, and muscle content compared with non‐recurrence cases. Moreover, patches with mixed inflammatory cells, tumour cells, and muscle were significantly more prevalent in recurrence versus non‐recurrence cases. The model integrating AI‐extracted histopathological and human‐assessed clinicopathological information demonstrated high accuracy in predicting lymph node recurrence in patients with cT1‐2N0 tongue SCC.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>39159053</pmid><doi>10.1002/2056-4538.12392</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-6489-446X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2056-4538
ispartof The journal of pathology. Clinical research, 2024-09, Vol.10 (5), p.e12392-n/a
issn 2056-4538
2056-4538
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_1685a82c74b8467eabd5e58b18e3f05e
source Open Access: PubMed Central; Publicly Available Content Database; Wiley Open Access
subjects Adult
Aged
Aged, 80 and over
Artificial Intelligence
Cancer
Carcinoma, Squamous Cell - pathology
Cell culture
Datasets
Dissection
Female
Gene expression
Humans
Inflammation
Lymph nodes
Lymph Nodes - pathology
lymphatic metastasis
Lymphatic Metastasis - pathology
Lymphatic system
Machine learning
Male
Medical prognosis
Metastasis
Middle Aged
Neoplasm Recurrence, Local - pathology
Neoplasm Staging
Neural networks
Original
Pathologists
pathology
Prediction models
Predictive Value of Tests
Squamous cell carcinoma
Squamous Cell Carcinoma of Head and Neck - pathology
Support vector machines
Tomography
Tongue
tongue neoplasms
Tongue Neoplasms - pathology
Tumors
title Predicting lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma: collaboration between artificial intelligence and pathologists
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T09%3A09%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predicting%20lymph%20node%20recurrence%20in%20cT1%E2%80%902N0%20tongue%20squamous%20cell%20carcinoma:%20collaboration%20between%20artificial%20intelligence%20and%20pathologists&rft.jtitle=The%20journal%20of%20pathology.%20Clinical%20research&rft.au=Adachi,%20Masahiro&rft.date=2024-09&rft.volume=10&rft.issue=5&rft.spage=e12392&rft.epage=n/a&rft.pages=e12392-n/a&rft.issn=2056-4538&rft.eissn=2056-4538&rft_id=info:doi/10.1002/2056-4538.12392&rft_dat=%3Cproquest_doaj_%3E3094820093%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4192-5b22889e0aafc842370bd7823c2de5cc53b4edba23055e587d04f6c0a4b67c053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3109515772&rft_id=info:pmid/39159053&rfr_iscdi=true